show episodes
 
Empowered Patient Podcast with Karen Jagoda is a window into the latest innovations in digital health, the changing dynamic between doctors and patients, and the emergence of precision medicine. The show covers such topics as aging in place, innovative uses for wearables and sensors, advances in clinical research, applied genetics, drug development, and challenges for connected health entrepreneurs.
  continue reading
 
Artwork

1
mHealth Zone Live

mHealth Zone

icon
Unsubscribe
icon
Unsubscribe
Monthly
 
mHealth Zone Live is an Internet radio show that discusses the latest in mobile health and technology and interviews industry experts. Whether you’re a healthcare provider, professional, patient, or developer, mHealth Zone Live will help you navigate the exciting world of mobile health. Join the conversation using hashtag #mHealthZone.
  continue reading
 
Artwork

1
Digital Conversations

Lifelink Systems

icon
Unsubscribe
icon
Unsubscribe
Monthly
 
Conversational technology and patient engagement are two technology trends sweeping through the three trillion dollar healthcare industry. In these short, interactive discussions, industry experts talk about how and where innovation is impacting the customer experience at hospitals, pharmaceutical companies, and the vast array of related services in the industry.
  continue reading
 
Stephen Hays is a recovering addict, living with type-1 bipolar disorder. He spent years living in addiction, and with untreated mental illness while he went from West Point graduate, to Wall Street Banker to nearly taking his own life when he hit bottom. On this show you will hear stories of addiction, mental illness, recovery, hope, and wellness. You will also hear from clinicians, experts, doctors, entrepreneurs and others who are trying to lead other people to wellness. We would love to ...
  continue reading
 
Artwork

1
The Health Crossroad with Dr. Doug Elwood and Dr. Tom Elwood

Dr. Doug Elwood and Dr. Tom Elwood Presenting A Leading Podcast on Health, Business, and Leadership with Amazing Featured Guests From Around Health

icon
Unsubscribe
icon
Unsubscribe
Monthly
 
Health care is currently at a crossroad. It represents 18 percent of GDP in the United States, the largest economy in the world, and faces multiple challenges but with many opportunities for improvement. Health permeates the life of every individual in some form or fashion. The Health Crossroad explores this world. We invite you to listen and participate, both on our podcast and our accompanying website, where we will post summaries and key concepts from each interview as well as advice and ...
  continue reading
 
Loading …
show series
 
Ali Morin, Chief Nursing Informatics Officer at symplr, emphasizes the need to focus on the challenges nurses face and AI's potential to reduce administrative burdens and nurse burnout. Significant staffing shortages, scheduling challenges, and increased patient acuity demand better data analytics and technology implementation to allow nurses to sp…
  continue reading
 
Ali Morin, Chief Nursing Informatics Officer at symplr, emphasizes the need to focus on the challenges nurses face and AI's potential to reduce administrative burdens and nurse burnout. Significant staffing shortages, scheduling challenges, and increased patient acuity demand better data analytics and technology implementation to allow nurses to sp…
  continue reading
 
Maggie Cline, Executive Director at EyeCare4Kids Utah, highlights the importance of providing eye exams and eyeglasses to underserved children, their parents, and those in shelters, refugee camps, and Native American reservations. Early testing and glasses with the correct prescription can significantly impact academic performance, confidence, and …
  continue reading
 
Maggie Cline, Executive Director at EyeCare4Kids Utah, highlights the importance of providing eye exams and eyeglasses to underserved children, their parents, and those in shelters, refugee camps, and Native American reservations. Early testing and glasses with the correct prescription can significantly impact academic performance, confidence, and …
  continue reading
 
Olivier Visa, President and CEO of Evergen specializes in developing and manufacturing biomaterials for use in regenerative medicine. These customized biomaterial solutions use xenografts, allografts, and emerging technologies inside and outside the body with applications in wound healing, cardiac, dental, breast, neuro, and spine repair. This appr…
  continue reading
 
Olivier Visa, President and CEO of Evergen specializes in developing and manufacturing biomaterials for use in regenerative medicine. These customized biomaterial solutions use xenografts, allografts, and emerging technologies inside and outside the body with applications in wound healing, cardiac, dental, breast, neuro, and spine repair. This appr…
  continue reading
 
Dr. Rekha Kumar, Chief Medical Officer at Found, is focused on weight care, not just weight management, to provide personalized medical care. GLP-1 medications have changed the landscape of obesity treatment, providing doctors with more effective tools for patients, but they don't work for everyone. With this telehealth approach, patients engage wi…
  continue reading
 
Dr. Rekha Kumar, Chief Medical Officer at Found, is focused on weight care, not just weight management, to provide personalized medical care. GLP-1 medications have changed the landscape of obesity treatment, providing doctors with more effective tools for patients, but they don't work for everyone. With this telehealth approach, patients engage wi…
  continue reading
 
Tim Tobin, CEO and Founder of Planatome, has a background in the semiconductor industry where precision polishing techniques were developed. Planatome has used that technology to create molecularly smooth scalpel blades that remove all the jagged edges on traditional surgical scalpels. These new nano polished blades significantly reduce scarring an…
  continue reading
 
Tim Tobin, CEO and Founder of Planatome, has a background in the semiconductor industry where precision polishing techniques were developed. Planatome has used that technology to create molecularly smooth scalpel blades that remove all the jagged edges on traditional surgical scalpels. These new nano polished blades significantly reduce scarring an…
  continue reading
 
Kiran Nistala, Chief Medical Officer and head of development at Zura Bio, describes how their novel molecules target multiple pathways to provide more effective treatments for patients with autoimmune diseases. This is particularly necessary for those with complex, heterogeneous manifestations not well addressed by current therapies. Zura Bio's nov…
  continue reading
 
Kiran Nistala, Chief Medical Officer and head of development at Zura Bio, describes how their novel molecules target multiple pathways to provide more effective treatments for patients with autoimmune diseases. This is particularly necessary for those with complex, heterogeneous manifestations not well addressed by current therapies. Zura Bio's nov…
  continue reading
 
Dr. Rafael Amado, President, Head of Global Research and Development at Zai Lab, highlights the renewed interest in antibody-drug conjugates (ADCs) with advancements in linker technology and payload delivery, leading to improved therapeutic windows and reduced side effects. The Zai Lab lead ADC ZL-1310 has shown promising results in small cell lung…
  continue reading
 
Dr. Rafael Amado, President, Head of Global Research and Development at Zai Lab, highlights the renewed interest in antibody-drug conjugates (ADCs) with advancements in linker technology and payload delivery, leading to improved therapeutic windows and reduced side effects. The Zai Lab lead ADC ZL-1310 has shown promising results in small cell lung…
  continue reading
 
Dr. Halinder Mangat, Director of Research at the Brain Trauma Foundation, has developed evidence-based guidelines for treating severe traumatic brain injuries, which have been shown to improve outcomes significantly. The Foundation is conducting research in collaboration with the US Defense Department and Veterans Administration, including a clinic…
  continue reading
 
Dr. Halinder Mangat, Director of Research at the Brain Trauma Foundation, has developed evidence-based guidelines for treating severe traumatic brain injuries, which have been shown to improve outcomes significantly. The Foundation is conducting research in collaboration with the US Defense Department and Veterans Administration, including a clinic…
  continue reading
 
Jeffrey Meckler, CEO of Indaptus Therapeutics, is focused on using their decoy platform to activate the immune system to fight cancer and infections. This approach activates the innate and adaptive pathways in a controlled manner using a short-term pulsed dosing regimen and helps avoid the toxicity issues seen in other immunotherapies. The therapy …
  continue reading
 
Jeffrey Meckler, CEO of Indaptus Therapeutics, is focused on using their decoy platform to activate the immune system to fight cancer and infections. This approach activates the innate and adaptive pathways in a controlled manner using a short-term pulsed dosing regimen and helps avoid the toxicity issues seen in other immunotherapies. The therapy …
  continue reading
 
Dr. Charles Bridges, the CSO at CorVista Health, has developed a cardiovascular diagnostic platform that uses a simple device to collect various heart signals. The platform then sends that data to the cloud for fast machine learning-based analytics, which can detect conditions like pulmonary hypertension and coronary artery diseases. This test can …
  continue reading
 
Dr. Charles Bridges, the CSO at CorVista Health, has developed a cardiovascular diagnostic platform that uses a simple device to collect various heart signals. The platform then sends that data to the cloud for fast machine learning-based analytics, which can detect conditions like pulmonary hypertension and coronary artery diseases. This test can …
  continue reading
 
Sean Ainsworth, the CEO of Immusoft, is developing novel cell therapies by programming B cells to produce therapeutic proteins, including antibodies, enzymes, signaling proteins, and other protein types. This autologous cell therapy has shown promising results in early clinical trials for enzyme replacement therapies for rare lysosomal storage diso…
  continue reading
 
Sean Ainsworth, the CEO of Immusoft, is developing novel cell therapies by programming B cells to produce therapeutic proteins, including antibodies, enzymes, signaling proteins, and other protein types. This autologous cell therapy has shown promising results in early clinical trials for enzyme replacement therapies for rare lysosomal storage diso…
  continue reading
 
Joy Duemke, Director of Marketing North America at Terumo, BCT, and Barry Liden, President and Managing Advisor of Patient Voice Advisors, highlight the importance of medical device companies engaging with patient associations to incorporate patient feedback into the design and development of their products. Patients can provide unique insights to …
  continue reading
 
Joy Duemke, Director of Marketing North America at Terumo, BCT, and Barry Liden, President and Managing Advisor of Patient Voice Advisors, highlight the importance of medical device companies engaging with patient associations to incorporate patient feedback into the design and development of their products. Patients can provide unique insights to …
  continue reading
 
Dr. Simrit Parmar, Founder of Cellenkos, is developing T regulatory cell therapies from cord blood to treat aplastic anemia, myelofibrosis, and acute lymphoblastic leukemia. Their three-prong strategy focuses on resolving inflammation and alleviating the burden of transfusions. Treg cells from cord blood are naturally tolerant and do not risk rejec…
  continue reading
 
Dr. Simrit Parmar, Founder of Cellenkos, is developing T regulatory cell therapies from cord blood to treat aplastic anemia, myelofibrosis, and acute lymphoblastic leukemia. Their three-prong strategy focuses on resolving inflammation and alleviating the burden of transfusions. Treg cells from cord blood are naturally tolerant and do not risk rejec…
  continue reading
 
Jay Hartenbach, the President and COO of Diakonos Oncology, is developing a dendritic cell therapy to treat late-stage and aggressive cancers like glioblastoma and pancreatic cancer. This approach uses the patient's cells and tumor tissue to generate a personalized treatment. The resulting vaccination tricks the immune system to attack cancer cells…
  continue reading
 
Jay Hartenbach, the President and COO of Diakonos Oncology, is developing a dendritic cell therapy to treat late-stage and aggressive cancers like glioblastoma and pancreatic cancer. This approach uses the patient's cells and tumor tissue to generate a personalized treatment. The resulting vaccination tricks the immune system to attack cancer cells…
  continue reading
 
Loading …

Quick Reference Guide

Listen to this show while you explore
Play